MedPath

Anti-inflammatory Effect of Peroperative Stimulation of the Vagus Nerve

Phase 3
Completed
Conditions
Postoperative Ileus
Interventions
Procedure: Sham stimulation
Procedure: Vagus stimulation
Registration Number
NCT02524626
Lead Sponsor
KU Leuven
Brief Summary

Hypothesis:

Electrical stimulation of the abdominal vagus nerve has anti-inflammatory effects which lead to a faster postoperative recovery after abdominal surgery.

Aims:

In the present study, the investigators want evaluate the anti-inflammatory effect of peroperative electrical stimulation of the vagus nerve. In addition, the investigators want to determine whether vagus nerve stimulation leads to a faster postoperative recovery. To this end, the following aims are formulated:

1. to determine whether vagus nerve stimulation leads to an improvement in gastrointestinal transit using radiological testing

2. to evaluate whether electrical stimulation of the vagus nerve leads to clinical improvement (daily questionnaire)

3. to show that electrical stimulation of the intra-abdominal vagus nerve reduces the inflammatory response to abdominal surgery

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
130
Inclusion Criteria
  • patients with ovarium, pancreas or colorectal carcinoma eligible for resection
Exclusion Criteria
  • preoperative therapeutic abdominal radiation shorter than 2 weeks prior to surgery
  • evident intra-abdominal inflammation (diagnosed by imaging and/or laboratory test results, including abscess or cholecystitis)
  • American Society of Anesthesiologists physical-health status classification (ASA-PS) > 3
  • poorly regulated diabetes (> 200 mg/dl (= 11 mmol/l)
  • surgery due to chronic pancreatitis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham stimulationSham stimulationno stimulation of vagus nerve
Vagus stimulationVagus stimulationStimulation of the vagus nerve at the beginning and the end of the surgery
Primary Outcome Measures
NameTimeMethod
The gastrointestinal transit (geometric mean)From postoperative day 3 until postoperative day 7
Secondary Outcome Measures
NameTimeMethod
Time to tolerance of oral food intake and first defecationFrom the date of surgery until the date of discharge from the hospital (on average 14 days)
Time to first flatusFrom the date of surgery until the date of discharge from the hospital (on average 14 days)
Gastrointestinal symptoms (nausea, pain, vomiting, bloating)From the date of surgery until the date of discharge from the hospital (on average 14 days)
Gastric stasis (volume of gastric fluid produced by gastric tube on postoperative day 1From the date of surgery until postoperative day 1
Time to first defecationFrom the date of surgery until the date of discharge from the hospital (on average 14 days)
Time to tolerance of oral food intakeFrom the date of surgery until the date of discharge from the hospital (on average 14 days)
Time to discharge from the hospitalFrom the date of surgery until the date of discharge from the hospital (on average 14 days)
Levels of pro-inflammatory cytokines in intestinal tissue, serum, peritoneal lavage and supernatant of stimulated whole bloodFrom the date of surgery until the date of lab analysis (up to 6 months)

Trial Locations

Locations (1)

University Hospitals Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath